EUVIMEDEUVIMED entdecken
Crossref

Commentary: is segmentectomy curative in patients with early-stage ground glass opacity predominant non-small cell lung cancer?

Abdulrahman Y. Hammad, Hiran C. Fernando

AME Clinical Trials Review · 2024

DOI: 10.21037/actr-23-38 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AME Clinical Trials Review, 2024. Verfasst von Abdulrahman Y. Hammad und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Hammad, A. Y., & Fernando, H. C. (2024). Commentary: is segmentectomy curative in patients with early-stage ground glass opacity predominant non-small cell lung cancer?. AME Clinical Trials Review. https://doi.org/10.21037/actr-23-38

Vancouver

Hammad AY, Fernando HC. Commentary: is segmentectomy curative in patients with early-stage ground glass opacity predominant non-small cell lung cancer?. AME Clinical Trials Review. 2024. doi:10.21037/actr-23-38

BibTeX
@article{Hammad2024,
  author = {Hammad, Abdulrahman Y. and Fernando, Hiran C.},
  title = {Commentary: is segmentectomy curative in patients with early-stage ground glass opacity predominant non-small cell lung cancer?},
  journal = {AME Clinical Trials Review},
  year = {2024},
  doi = {10.21037/actr-23-38}
}
Kostenlos starten →